February has been a gloomy and chilly month so far, and the cold air has no plans to leave. The cooler pattern this week will ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged ...

After a pleasant week of spring-like temperatures in the area, a pattern shift will bring a warm front and a strong cold front through the area this weekend. Not only is the cold front going to ...

British workers are heading back to the office in greater numbers, but their commuting habits are changing in unexpected ways. According to the latest Movers Index from Virgin Media O2 Business, 88% ...

Quick commerce platform Zepto has completed its reverse merger from Singapore to India, a key step in its preparations for an initial public offering (IPO). Chief financial officer (CFO) Ramesh Bafna ...

President Trump’s Saturday night proposal that Palestinians vacate a devastated Gaza marked a sharp break with his predecessor and introduced a contentious new initiative into his unfolding ...

Millions of Canadians won't be in the deep freeze to kick off February as a forthcoming pattern change will reconfigure air masses in the country The Arctic chill draining across the U.S. over the ...

Six students were announced among the top 40 finalists in the Regeneron Science Talent Search Competition. The students were chosen based on their research, leadership skills and commitment to ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...